Jpmorgan Chase & CO ENLIVEN THERAPEUTICS INC Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024
Number of Shares
19,745
Previous 20,807 5.1%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
N/A
-1,062 Reduced 5.1%
19,745 $0
Q3 2024

Dec 26, 2024
BUY
N/A
13 Added 0.06%
20,807 $0
Q3 2024

Nov 08, 2024
BUY
N/A
13 Added 0.06%
20,807 $0
Q2 2024

Dec 26, 2024
SELL
N/A
-13 Reduced 0.06%
20,794 $0
Q2 2024

Aug 12, 2024
BUY
N/A
2,407 Added 13.09%
20,794 $0
Q1 2024

Dec 26, 2024
SELL
N/A
-2,420 Reduced 11.63%
18,387 $0
Q1 2024

May 10, 2024
SELL
N/A
-5,602 Reduced 23.35%
18,387 $0
Q4 2023

Dec 26, 2024
BUY
N/A
3,182 Added 15.29%
23,989 $0
Q4 2023

Feb 12, 2024
SELL
N/A
-2,506 Reduced 9.46%
23,989 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-4,160 Reduced 13.57%
26,495 $0
Q2 2023

Aug 11, 2023
BUY
N/A
30,561 Added 32511.7%
30,655 $0
Q1 2023

May 11, 2023
BUY
N/A
94 New
94 $0
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email